Form 8-K - Current report:
SEC Accession No. 0001193125-24-181093
Filing Date
2024-07-18
Accepted
2024-07-18 17:19:32
Documents
15
Period of Report
2024-07-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d771601d8k.htm   iXBRL 8-K 28590
2 EX-99.1 d771601dex991.htm EX-99.1 5141
6 GRAPHIC g771601dsp6.jpg GRAPHIC 9227
  Complete submission text file 0001193125-24-181093.txt   169172

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20240717.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20240717_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20240717_pre.xml EX-101.PRE 10816
17 EXTRACTED XBRL INSTANCE DOCUMENT d771601d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 241125468
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)